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Abstract
Balanites aegyptiaca (L.) Del (Balanitaceae) is traditionally used for the treatment of various ailments such as syphilis, jaundice 
and liver disorders, epilepsy. This study was designed to evaluate acute toxicity and hepatoprotective effect of aqueous extract of 
Balanites aegyptiaca on CCl4 induced hepatotoxicity in rats. Acute toxicity was assessed with the extract at a dose of 2000 mg /
kg bw. The extract at doses of 25, 50 and 100 mg / kg b.w. was orally administered respectively to CC14-induced hepatotoxicity 
(0.5 ml / kg) animals. Silymarin (100 mg / kg) was given as a reference. Biochemical parameters such as ALT, AST, PT, ALB 
and ALP were assayed as well as enzymatic antioxidant activities SOD, CAT and MDA. Nitrogen monoxide (NO) involved in 
inflammation was a lso m easured. A ctivities o f l iver m arker e nzymes, A LT, A ST a nd A LP, t otal p rotein, a lbumin a nd s howed a 
significant hepatoprotective effect. Regarding antioxidant enzymatic activities i n v ivo (SOD, CAT and MDA) of aqueous extract 
exhibited a significant effect showing increasing levels of SOD, CAT and reducing malondialdehyde (MDA) levels. The production 
of NO is significantly reduced compared to the batch intoxicated by CCl4. Balanites aegyptiaca is endowed with hepatoprotective 
properties that can be attributed to antioxidant potential which could justify its use in traditional medicine in liver disorders.
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Introduction
The main causes of liver damage are viral infections (B and
C), parasitic infections, mycotoxins, alcohol, drugs, autoimmune
diseases and metabolic syndromes (obesity, insulin resistance
and diabetes) [1]. These liver lesions cause the activation of sev-
eral endogenous mediators, in particular the metabolism of reac-
tive oxygen species (ROS) by cellular damage [2]. These ROS
can cause deleterious lipid peroxidation of cell membranes lead-
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ing to a number of liver diseases such as fibrosis, cirrhosis and
hepatocellular carcinoma [3]. This production of ROS may be-
come excessive or result from exogenous toxic phenomena and
the body will have to protect itself from these excesses by differ-
ent antioxidant systems. Endogenous antioxidant enzymes fail
to reduce the excessive production of ROS resulting in their ac-
cumulation in the body [4]. This can lead to disorganization of
biochemical parameters and massive production of nitric oxide
(NO) involved in inflammation.
To overcome this deficit, the use of exogenous antioxidants
is more than necessary thanks to the drugs used in the manage-
ment of hepatitis allowing the liver to recover to rebalance the
internal imbalance. People in developing countries use herbal
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medicines to treat liver disease. Increasingly, it is necessary to
evaluate natural compounds as effective alternatives. The more
and more studied herbal medicines have shown their proofs in
the use of natural antioxidants in the improvement of antioxi-
dant enzymatic activities and the restoration of biochemical pa-
rameters [5]. It has been found that hepatoprotective effects are
directly associated with phytoconstituents.
Balanites aegyptiaca L. Delile, (Balanitaceae), known for its
many therapeutic properties, is a shrub native to Asia and North
Africa and located in arid regions [6]. These fruits are of great
nutritional interest and all parts of the plant are used in the treat-
ment in traditional medicine of various pathologies such as can-
cer, hemorrhoids, stomach aches, jaundice, yellow fever, [7]. In
Burkina Faso, the whole root is used in the treatment of chronic
hepatitis in traditional medicine [8]. Despite this strong use in
traditional medicine, some studies on this part of the plant have
not yet been studied. The objective of this study was to study the
hepatoprotective effects of aqueous extract of Balanites aegypti-
aca on hepatotoxicity induced by carbon tetrachloride in rats.
Material and methods
Chemical reagents
Sodium phosphate monobasic (NaH2PO4), sodium phosphate
dibasic (Na2HPO4), ethylenediamine tetra acetic acid (EDTA),
sylimarine, N-(1- naphthyl) ethylenediamine dihydrochloride,
Sulfanilamide and Carbon tetrachloride (CCl4) are from SIGMA
aldrich (Steinheim, Germany). Iron chloride (FeCl3), Sodium
carbonate (Na2CO3) and phosphoric acid (H3PO4) are from
Fluka chemic reagents (Buchs, Switzerland) and prochimic.
They were all of analytical grade. Kits for examining albumin,
alanine transaminase (ALT), aspartate transaminase (AST), al-
kaline phosphatase (ALP), Total protein, Albumin obtains by
SpinReact, Girona, Spain. Other products and reagents such as
ethanol, hydrogen peroxide (H2O2) were also used.
Animals
NMRI male mice 1-2 months old weighing 25-30 g from the In-
stitute of Research in Health Science (IRSS) pet shop were used
for the acute toxicity studies. Normal male and female rats of
3-4-month-old WISTAR strains weighing between 150 and 170
g were used for the hepatotoxicity activity. They were fed wheat
cake (29% protein) and running water. They were raised under
air conditioning (23-25 ◦ C) and 60% humidity. All experiments
were conducted in the morning in accordance with the Labo-
ratory Animal Care Guidelines and the Ethical Guidelines for
Painful Experimentation on Conscious Animals [9].
Plant materials and extraction
Root barks of plant were harvested in Ouagadougou in 2015.
Specimen was identified by Pr Amado OUEDRAOGO and was
deposited at the herbarium of the university Joseph KI-ZERBO
against a code number T4263. Drying was carried out under
dust-free ventilation, then the plant material was ground and
stored in a vacuum plastic bag in a desiccator.
Fifty grams of the powder were extracted in 500 ml of dis-
tilled water and extract has been frozen and lyophilized. The
lyophilizate obtained (12.5 g) was stored in a vacuum desiccator
for later use.
Acute toxicity test
Acute toxicity of aqueous extracts of root bark of Balanites ae-
gyptiaca was performed on male NMRI mice according to the
OECD test guideline 423 [10]. After 4 h of fasting, a single dose
of 2000 mg / kg body weight of extract was were administered
orally by gavage. Animals were observed individually during the
first 2 h post-treatment for signs of toxicity and after that, fed
was restored. They were then observed at least once a day for 14
days to detect mortality [11] .
Hepatoprotective activity
Experimental protocol
Wistar rats weighing between 150 and 170 g were placed in
cages in groups of seven animals with access to fed pellets and
tap water. The rats were divided into 7 groups of 7: Lot I (con-
trol) received a single dose of olive oil (0.5 ml / kg body weight
p.o.); lot II, carbon tetrachloride (CCl4) at the dose of 0.5 ml /
kg body weight i.p; lot III, a reference (sylimarin) antioxidant at
a daily dose of 100 mg / kg body weight p.o. with CCl4 [12].
The test lots (IV, V and VI) received variable doses (25, 50 and
100mg / kg of bw) of the aqueous extracts of Balanites aegyp-
tiaca once daily. A lot VII was constituted to receive only the
extract at the dose of 100 mg / kg of bw. All treatments were
administered orally for 6 days. On day 7, exception of lots I and
VII, animals from the other lots were injected with CCl4 (0.5
mg / kg, i.p, body weight). Animal weight, food consumption
and water were recorded daily during the 7 days.
After administration of CCl4, the rats were fasted overnight
for 12 h. All rats were anesthetized using ketamine (150 mg/
kg, i.p) and blood was collected directly by heart puncture and
was allowed to clot before centrifugation at 3000g for 10 min
to separate serum. The sera obtained were stored at -20◦C for
later biochemical analysis (ALT, AST, PT, ALB and ALP) and
inflammatory marker levels (NO). All animals were then sacri-
ficed and the liver were collected in ice cold and divided in two
parts: a fine part was washed twice with ice cold 0.1 M PBS
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(phosphate buffer saline), pH 7.2, blotted and dried. A 10% ho-
mogenate of the tissues of each rat were prepared in PBS. This
homogenate was centrifuged at 12,000 g for 1 h at 4 ◦ C. The
resulting supernatant was used for the determination of antioxi-
dant activity in vivo (MDA, CAT, SOD).
Assay of biochemical analyses and determination of
antioxidant enzyme activities
ALAT / GPT, ASAT / GOT, PAL, Albumin, and total pro-
teins were measured using a specific diagnostic kit (SpinReact,
Girona, Spain). Catalase [13], SOD [14] and MDA [15] was
evalued. The NO2 levels in serum were determined [16].
Statistical analysis
Statistical analysis was performed using one-way analysis of
variance (ANOVA) followed by Bonferroni’s multiple compara-
ison test using GraphPad Prism 6 (Graph Pad Software Inc.,




The aqueous extract of root barks showed not symptoms of tox-
icity or mortality at the single dose of 2000 mg / kg body weight
during the two-week post-treatment observation period.
Hepatoprotective activity assay
Effect of plant extract on animal physical parameter
Experimentation during seven days was not influenced on ani-
mals’ weight (figure 1). The consumption of food (Figure 2) and
water (Figure 3) were not affected equally by the administration
of B. aegyptiaca aqueous extract.
Assay of biochemical parameters
Administration of CCl4 to rats resulted in a considerable in-
crease in Alt, Ast and PAL and a decrease in protein and al-
bumin (Table 1). On the other hand, for treated groups with the
extract (25, 50 and 100 mg/Kg bw), its parameters decreased
with respect to the parameters of negative group. The 50 mg /
kg extract give the best biochemical parameters compared to the
25 and 100 mg / kg doses after the CCL4 injection. It is noted
that the extract alone allowed a protection of the liver through
the biochemical parameters comparable to those of control.
Antioxidant enzymatic activity
The action of CCl4 significantly reduced the activity of CAT,
SOD while increasing the content of MDA (Table 2). The in-
Figure 1 The body weight of the rats
Figure 2 Food consomption
crease in MDA was attenuated by the administration of extract
at different doses (25, 50 and 100 mg / kg bw) as well as the
increase in CAT and SOD. Serum NO was elevated in the CCl4
group compared to the other groups.
Discussion
In the acute toxicity test, according to OECD guideline 423, the
LD50 was estimated at 5000 mg / kg of body weight and this
allows the extract to be classified in category 5 of the Glob-
ally Harmonized System (GHS) of the OECD and the United
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Table 1 Effect of ethanolic extract of Balanites aegyptiaca on serumbiochemical parameters on CCl4 Induced hepatotoxicity in rats.
ALT (UI/L) AST (UI/L) Creatinin (umol/L) Protein T (g/L) Albumin (g/L) PAL (UI/L)
Control 31,43±4,08 99±5 65,3±3,4 64,63±3,24 43,32±2,14 133,8±24,96
CCl4 0,5 ml/Kg bw 790±65 697,5±52,5 69,68±2,10 55,6±0,95 34,23±3,02 357,8±5,12
Silymarin 100 mg/ Kg + CCl4 84,6±18,32 182,5±59 65,2±5,2 58,67±1,87 40,89±3,75 237±21,5
Extract 25 mg/ Kg + CCl4 72±20 163±73,5 65,34±4,66 58,4±2,1 34,49±1,47 256,86±56,69
Extract 50 mg/ Kg + CCl4 46±0,12 103±1,25 59,96±7,79 55,22±4,05 35±1,4 210,17±44,56
Extract 100 mg/ Kg + CCl4 95±25 158,89±35,44 64,14±2,35 60,6±2,86 36,06±0,93 234±37
Extract 100 mg/ Kg 53±7,33 174,67±40,44 66,68±4,54 66,63±3,1 41,16±0,87 203±16,22
Values are means ± SEM (n=7).aP < 0.05, significant change withrespect to Control; bP < 0.05, significant change withrespect to CCl4 0,5ml/Kg
Table 2 Effect of aqueous extract ofBalanites aegyptiaca on liver antioxidant parameters on CCl4induced injury in rats
Cat mmol/mg MDA mmol/mg SOD mmol/mg NO (µg/ml)
Control 12,58±0,61 0,17±0,01 9,66±0,98 0,40±0,11
CCl4 0,5 ml/Kg 4,77±1,95 a 0,20±0,03 a 7,06±1,01 a 0,53±0,13 a
Silymarin 100 mg/ Kg + CCl4 10,42±2,24 a,b 0,16±0,03 9,37±2,32 0,47±0,15
Extract 25 mg/ Kg + CCL4 11,75±2,54 a,b 0,17±0,03 9,46±1,79 0,43±0,16
Extract 50 mg/ Kg + CCl4 12,55±1,71 a,b 0,18±0,05 9,29±1,15 0,44±0,11
Extract 100 mg/ Kg + CCl4 12,27±0,82 a,b 0,16±0,03 9,61±0,56 0,51±0,09
Extract 100 mg/ Kg 14,85±2,47 a,b 0,17±0,02 9,46±1,19 0,49±0,13
Valuesare means ± SEM (n=7). aP< 0.05, significant change with respect to Control; bP< 0.05, significant
change with respect to CCl4 0,5ml/Kg
Figure 3 Water consomption
Nations [10, 17]. This result suggests that the plant extract has
relatively low acute oral toxicity [10].
The extract and silymarin do not interfere with the behav-
ior and eating habits of the animals. The elevation of AST is
attributed to a hepatocellular lesion in rats, that of ALT linked
to the necrotic state and the action of ALP is linked to hepa-
tocyte function (evaluation of obstructive hepatic lesion) [18] .
In this study, the increase in the level of its biochemical param-
eters in rats is due to liver failure leading to their release into
the blood compared to normal rats. Rats treated with the extract
at different doses saw their levels of ALT, AST and ALP de-
crease depending on the dose used. This analysis demonstrated
the hepatoprotective effects of Balanites aegyptiaca root bark
extract on liver damage by induction of CCl4 [19]. Reduction in
total protein and albumin levels is considered a useful indicator
of the severity of hepatocellular dysfunction [20]. Stimulation
of protein biosynthesis has been suggested as a hepatoprotective
mechanism that improves the regenerative process of hepatocyte
production [20]. The action of the extract would stimulate the
biosynthesis of these parameters.
The action of CCl4 on rats led to a decrease in SOD and CAT
activities which could be linked to a hyperproduction of radicals
exceeding the production of its enzymes. Its results are in line
with the results of the work carried out by Eidi A and al., [19],
Wang R and al., [21] and Al-Olayan EM and al., [22]. The ac-
tion of the different doses of the extract on the liver tissue cells
led to improve the production of SOD and CAT. Its results are
in agreement with the results of Suky TMG and al., [23] that
found that the extract of the aerial parts of Balanites aegypti-
aca was able to prevent the decrease of SOD and CAT activities
that could be correlated with neutralization radicals. They also
corroborate from those of Ali BH and al., [24] who had found a
modest hepatoprotective activity of Balanites aegyptiaca against
damage caused by paracetamol.
CCl4-induced liver damage causes liver levels of MDA and
serum nitric oxide (NO) to increase. The LPO caused by the ad-
ministration of CCl4, leads to a large production of free radicals
followed by a decrease in the antioxidant defense causing oxida-
tive stress. Hepatic MDA was evaluated to estimate the hepato-
protective effect of Balanites aegyptiaca extract in rats treated
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with CCl4 [25]. In this study, MDA levels were reduced by dif-
ferent doses of extracts and silymarin (reference substance). NO
production in CCl4-induced liver injury at animal is released by
inducible nitrite oxide synthase (iNOS) expression [26]. A de-
crease in the production of NO in the serum in rats treated with
the extract of Balanites aegyptiaca would show the capacity to
block the inflammatory activity induced by CCL4 on the liver.
Al-Olayan et al., found in their study an increase in NO produc-
tion in rats dependent on CCl4 and a decrease in rats treated with
CCl4 with their extract [22].
Conclusion
The results of this study indicated that the aqueous extract of the
root bark of Balanites aegyptiaca had a preventive effect against
liver damage induced by CCl4 in rats. Its action has inhibited
the production of oxidative stress in rats, restoring the level of
biochemical indicators in serum and liver tissues and proteins in
liver tissues. The extract prevented liver damage caused by the
oxidative stress of CCl4. Additional studies will be carried out to
characterize and discover the mechanism of action of the active
compounds in the aqueous extract of Balanites aegyptiaca which
are at the origin of the hepatoprotective activity observed.
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